Moreover, the role of IGF-2 in the brain is also sustained by data showing its alterations as a common feature across a variety of psychiatric and neurological disorders, including schizophrenia, Alzheimer’s disease, depression, and so on (21) Pai et al. This evidence concerns the gene IGF2 and depressive symptom measurement.